ProKidney Corp. (PROK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.23
• Market Cap: $679.89M
• EPS: $-0.55
• 52-Week High: $5.95
• 52-Week Low: $0.46

About ProKidney Corp.

ProKidney Corp., based in Winston-Salem, North Carolina, is a leading biotechnology firm dedicated to revolutionizing the management of chronic kidney disease (CKD). The company's innovative approach focuses on cell-based therapies designed to restore kidney function and enhance the quality of life for patients suffering from this pervasive condition. With a strong development pipeline and a mission centered on advancing renal health, ProKidney is well-positioned in the biopharmaceutical land...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ProKidney Corp. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PROK pay dividends?

ProKidney Corp. (PROK) does not currently pay a regular dividend.

What is PROK's market cap?

ProKidney Corp. (PROK) has a market capitalization of $679.89M with a current stock price of $2.23.